COMP <GO>
FCEL vs ACCV // ALTMAN Z-SCORE & DEBT/EQUITY
FuelCell Energy Inc. (NASDAQ) VS. Accelevation Holdings Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: FCEL 0
— ACCV 2
■ METRIC PARITY
LAST: $12.18 (-1.62%) • MKT CAP: $973.8M
balance-sheet
0.20
LAST: $15.19 (+1.07%) • MKT CAP: $3.59B
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FCEL VS. ACCV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FCEL | ACCV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -16.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.87% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 41.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.1 | 43.7 | -8.62 | ACCV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $973.8M | $3.59B | -$2.62B | ACCV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FCEL REV | ACCV REV | FCEL GROSS % | ACCV GROSS % | FCEL FCF | ACCV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $158.2M | — | -16.7% | — | -$125.3M | — |
| FY 2024 | $112.1M | — | -32.0% | — | -$152.9M | — |
| FY 2023 | $123.4M | — | — | — | -$140.3M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FCEL // BETA —
ACCV // BETA —